Congenital Heart Futures Reauthorization Act of 2024

Bill 118 s 3757, also known as the Congenital Heart Futures Reauthorization Act of 2024, is a piece of legislation that aims to continue and expand upon the efforts of the original Congenital Heart Futures Act. This bill focuses on improving research, data collection, and awareness surrounding congenital heart defects, which are the most common type of birth defect in the United States.

The main provisions of this bill include reauthorizing funding for the Centers for Disease Control and Prevention (CDC) to collect data on congenital heart defects, as well as funding for the National Institutes of Health (NIH) to support research on the causes and treatments of these defects. The bill also aims to improve coordination among federal agencies, healthcare providers, and patient advocacy groups to ensure that individuals with congenital heart defects receive the best possible care.

Additionally, the Congenital Heart Futures Reauthorization Act of 2024 includes provisions to support education and awareness initiatives to help individuals and families affected by congenital heart defects. This includes funding for programs that provide information and support to patients and families, as well as efforts to improve access to care for individuals with these conditions. Overall, this bill seeks to address the ongoing challenges faced by individuals with congenital heart defects and their families, and to improve outcomes for those affected by these conditions. By reauthorizing and expanding upon the original Congenital Heart Futures Act, this legislation aims to make meaningful progress in the fight against congenital heart defects in the United States.